This week’s issue of Cambridge Independent featured an article about our partnership with AstraZeneca and the University of Cambridge!
We are proud to see the field of dynamic single-molecule analysis reaching a new milestone once again. This brings us closer to our goal: improving human health by providing unparalleled insight into the fundamental cause of disease and potential for drug optimization.
For the full article, have a look on the Cambridge Independent website!
